16 нояб. 2014 г. · Dual antiplatelet therapy beyond 1 year after placement of a drug-eluting stent, as compared with aspirin therapy alone, significantly reduced the risks of ... |
The DAPT study evaluated the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention, with implications for clinical ... |
Continued DAPT (totaling 30 months) reduces the rate of stent thrombosis and death, MI, or stroke at the cost of increased bleeding. |
4 янв. 2024 г. · The STOPDAPT-2 trial showed that 1-month DAPT was superior to 12-month DAPT at preventing net adverse ischemic events. |
randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous ... |
Compared with DAPT for six to 12 months, extending DAPT for more than 12 months may reduce the risk of MI and probable or definite stent thrombosis but increase ... |
This review provides a comprehensive summary of the major trials that have informed current DAPT strategies, puts into context recent trials driving a shift ... |
Novbeti > |
Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |